| 08.30-10.00 |
Update on disease modification and disease management in osteoarthritis
Breakfast Symposium sponsored by ROTTAPHARM GROUP |
| 10.00-11.30 |
SESSION I
Chairmen: G. MAALOUF & H. MINNE |
10.00-10.30
PL1 |
Invited Lecture
Update on the Management of Vertebral Fractures: Clinical and Economic Aspects?
B. JONSSON |
| 10.30-11.30 |
Oral Communications of selected abstracts |
10:30-10:40
OC10 |
DENOSUMAB (AMG 162) INHIBITION OF RANK LIGAND INCREASES BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN AFTER
TWO YEARS OF TREATMENT
E.M. Lewiecki, P.D. Miller, M.R. McClung, S.B. Cohen, Y. Liu,
A. Wang, L.A. Fitzpatrick |
10:40-10:50
OC11 |
COST-EFFECTIVENESS OF BALLOON KYPHOPLASTY FOR SYMPTOMATIC VERTEBRAL COMPRESSION FRACTURES IN OSTEOPOROTIC PATIENTS
M. Marchetti, M. Caruggi, R. Taylor |
10:50-11:00
OC12 |
POSTMENOPAUSAL BONE FRAGILITY – A DISEASE OF FAILED ADAPTATION
P. Szulc, E. Seeman, F. Duboeuf, E. Sornay-Rendu, F. Munoz,
P.D. Delmas |
11:00-11:10
OC13 |
REDUCTION IN THE RISK OF BACK PAIN PERSISTS AT LEAST 30 MONTHS AFTER DISCONTINUATION OF TERIPARATIDE TREATMENT: A META-ANALYSIS
J.-Y. Reginster, M.C. Nevitt, P. Chen, R.K. Dore, D.P. Kiel,
J.R. Zanchetta, E.V. Glass, J.H. Krege |
11:10-11:20
OC14 |
THE DIFFERENTIAL EXPRESSION OF OPG/RANKL IN HUMAN OSTEOARTHRITIC SUBCHONDRAL BONE OSTEOBLASTS IS AN INDICATOR OF THE METABOLIC STATE OF THESE DISEASE CELLS
J. Martel-Pelletier, D. Lajeunesse, F. Mineau, H. Fahmi, M. Lavigne,
J-P. Pelletier |
| 11:30-12:00 |
Fellowship Awards Ceremony
Courtesy of AMGEN |
| 12.15-13.45 |
Multidimensional Impact of Postmenopausal Osteoporosis
Lunch Symposium sponsored by ELI LILLY |
| 13.45-15.00 |
Poster Viewing and Visit of the Exhibition
Poster P100 to P199 |
| 15.00-16.45 |
SESSION II
Chairmen: R. RIZZOLI & R. LORENC |
15.00-15.30
PL2 |
Invited Lecture
Update on the Management of Non Vertebral Fractures: Clinical and Economic Aspects?
C. COOPER |
| 15.30-16.45 |
Oral Communications of selected abstracts |
15:30-15:40
OC15 |
ARE COSTS OF FRACTURE PROPORTIONAL TO THEIR MORBIDITY?
F. Borgström, O. Johnell, B. Jönsson, J.A. Kanis |
15:40-15:50
OC16 |
NEED FOR ADDITIONAL CALCIUM TO REDUCE THE RISK OF HIP OR ANY NONVERTEBRAL FRACTURE WITH VITAMIN D
SUPPLEMENTATION: EVIDENCE FROM A COMPARATIVE META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
S. Boonen, D. Vanderschueren, P. Haentjens, P. Lips |
15:50-16:00
OC17 |
INCIDENCE OF HIP FRACTURE OVER A 10-YEAR PERIOD: REVERSAL OF A SECULAR TREND RELATED TO A SPECIFIC DECREASE OF THE
AGE-ADJUSTED INCIDENCE IN INSTITUTIONAL-DWELLING ELDERLY WOMEN
T. Chevalley, E. Guilley, F. Herrmann, P. Hoffmeyer, C.-H. Rapin, R. Rizzoli |
16:00-16:10
OC18 |
ADVANCED ATHEROSCLEROSIS IN THE LUMBAR AORTA POSES AN INCREASED RISK FOR FUTURE CARDIOVASCULAR EVENTS AND HIP
FRACTURES IN POSTMENOPAUSAL WOMEN
L.B. Tankó, Y.Z. Bagger, P. Alexandersen, C. Christiansen |
16:10-16:20
OC19 |
EFFECTS OF TIBOLONE AND RALOXIFENE ON BONE: RESULTS OF THE STEP STUDY
P.D. Delmas, S. Adami, S.R. Davis, S.C. van Os |
16:20-16:30
OC20 |
LASOFOXIFENE INCREASES THE SPINE AND HIP BMD AND DECREASES BONE TURNOVER MARKERS IN POSTMENOPAUSAL
WOMEN WITH LOW OR NORMAL BMD
M. McClung, E. Siris, S. Cummings, H. Bone, R. Recker, P. Delmas, J. Zanchetta, M. Lewiecki, C. Zerbini, S. Miller, K. Wolter, J. Proulx, R. Brunell,D. Radecki |
16:30-16:40
OC21 |
STRONTIUM RANELATE REDUCES THE RISK OF FRACTURE IN ELDERLY WOMEN WITH OSTEOPOROSIS IN THE FIRST YEAR OF TREATMENT
E. Seeman, B. Vellas, C.L. Benhamou, J.P. Aquino, J. Semler, J.-M. Kaufman, K. Hoszowski, A. Roces Varela, C.E. Fiore, K. Brixen, J.-Y. Reginster, S. Boonen |
| 17.00-18.30 |
The Future of Osteoporosis
Symposium sponsored by PFIZER |
| 18.45-20.15 |
Acting on Both Sides of the Equation in Postmenopausal Osteoporosis
Symposium sponsored by SERVIER |
 
|
